Trials / Not Yet Recruiting
Not Yet RecruitingNCT06796933
Effect of Bioptron on Scar Formation After Cesarean Section
Effect of Bioptron on Scar Formation After Cesarean Section: a Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study will be to determine the effect of polarized light therapy (Bioptron) on scar formation after a cesarean section.
Detailed description
Cesarean deliveries are among the most frequently performed surgical procedures for women worldwide, with their prevalence increasing globally, especially in developing nations like Egypt. A scar is a natural outcome of the healing process following a wound. Complaints associated with scars can lead to both physical discomfort and psychological challenges. Enhanced healing of CS scars could lead to better postoperative outcomes, reducing complications such as infection, pain, and restricted mobility. These aspects of recovery are often neglected, as noted by. This study will be the first to specifically examine the effects of Bioptron light therapy on CS scar formation. While previous research has shown the benefits of this therapy on scars from various operations, none have focused on CS scars. By investigating this innovative, non-invasive treatment approach, the study aims to fill a critical gap in existing research and offer valuable insights into managing and improving postoperative recovery for CS patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Silicon based products (silicon gel) | The participants will be treated with cosmetic creams such as Silicone-based products (silicone gels twice a day) for one month. |
| DEVICE | Bioptron (polarized light therapy) | The participants will be treated by polarized light therapy (Bioptron) for 15 minutes, 3 sessions per week, for one month. |
Timeline
- Start date
- 2025-01-27
- Primary completion
- 2025-03-18
- Completion
- 2025-03-31
- First posted
- 2025-01-28
- Last updated
- 2025-01-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06796933. Inclusion in this directory is not an endorsement.